This is Frame Title
This is Module Title
Click for Help
Click forPrint PDF
Click forReferences Popup
Click forGlossary Popup
Click forgoto Home
Click forPrevious frame
Click forNext frame
Click forTranscript Popup
Return to the Module
For Internal use only. This training material is for educational purposes only. It is not to be used, shared, or discussed with customers.
Please rotate your device 90° to landscape view.
Select a term from the list on the left
- FDA press release. FDA Web site. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm540945.htm. Accessed 2 May 2018.
- Emflaza [Prescribing Information]. Northbrook, IL: Marathon Pharmaceuticals, LLC.2017.
- Griggs RC, Miller JP, Greenberg CR, et al. Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy. Neurology. 2016;87:1-9.
- MRC Muscle scale. https://mrc.ukri.org/research/facilities-and-resources-for-researchers/mrc-scales/mrc-muscle-scale/. Accessed 9th July 2018.
- Neurology data supplement. Neurology Web site. http://n.neurology.org/content/neurology/suppl/2016/08/26/WNL.0000000000003217.DC1/e-figures.pdf. Accessed 2 May 2018.
- Angelini C, Pegoraro E, Turella E, Intino MT, Pini A, Costa C. Deflazacort in Duchenne dystrophy: study of long-term effect. Muscle Nerve. 1994;17(4):386-391.
Do you want to resume from where you left off?